跳至主要内容
临床试验/NCT02272322
NCT02272322Unknown不适用

Transvaginal Treatment of Symptomatic Cystocele Grade II-III Using Cousin Biomesh Soft Prolaps or Allium Medical Endofast Reliant

Slabbaert Koen1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2014年6月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
1
主要终点
Absence of recurrence

研究概览

简要总结

This observational study will evaluate treatment of symptomatic cystocele grade II-III with Cousin Biomesh and Allium Medical Endofast Reliant. Data about 100 patients will be collected. Follow-up till 3 years after the procedure. Primary endpoint is absence of recurrence.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
40 Years 至 90 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patient is a woman
  • Patient is between 40 and 90 years old
  • Patient has to sign the informed consent form prior to the procedure
  • Patient has to agree with the scheduled follow-up visits on month 1, month 6, year 1, year 2 and year 3
  • Patient has symptomatic anterior prolapse

排除标准

  • Recurrence cystocele
  • Patient is pregnant
  • Patient has a wish to become pregnant
  • Patient is taking Plavix, Sintrom, Marcoumar, Marevan, Brilique, Efient, Ticlid, Xarelto, Eliquis or Pradaxa. If intake is stopped prior to procedure, patient is allowed to be included.
  • Patient is taking LMWH in a dose of more than 40 mg/day
  • Patient has a life expectancy < 1 year
  • Patient has a known connective tissue disease
  • Patient has a history of surgery of the anterior vaginal wall or pelvis
  • A scheduled hysterectomy during the index-procedure

结局指标

主要结局

Absence of recurrence

时间窗: 3 years

次要结局

  • Technical success(day 1)
  • Procedural success(30 days)
  • Peroperative complications(day 1)
  • Postoperative complications(3 years)
  • Quality of life(3 years)

研究者

发起方
Slabbaert Koen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Slabbaert Koen

MD

Regionaal Ziekenhuis Heilig Hart Tienen

研究点 (1)

Loading locations...

相似试验